GlassScriptPhysician profile
Jeffrey R Monteith
NPI 1699895128
$7,763.79
in general payments reported to CMS, 2019-2025
49 companies · $1,449 in 2025
The $1,449 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,990 · 2020: $581 · 2021: $253 · 2022: $946 · 2023: $1,333 · 2024: $1,212 · 2025: $1,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,906 · Debt Forgiveness: $56.23 · Education: $31.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,906.47 |
| Debt Forgiveness | $56.23 |
| Education | $31.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,139.17 | 2019-2025 | |
| Pfizer INC. | $873.08 | 2019-2025 | |
| Glaxosmithkline, LLC. | $679.72 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $605.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $503.96 | 2019-2025 | Jardiance, Ofev, Synjardy |
| Amgen INC. | $446.82 | 2019-2025 | Otezla, Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $406.01 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $379.77 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $341.78 | 2019-2020 | |
| Abbott Laboratories | $246.18 | 2022-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $222.55 | 2019-2025 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Astellas Pharma US INC | $178.94 | 2019-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $128.71 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $123.30 | 2023-2025 | Gemtesa |
| Exact Sciences Corporation | $121.83 | 2023-2025 | Cologuard Collection Kit |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Monteith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.